Home Page ::: Current Drug Discovery Technologies

ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)


Volume 14, 4 Issues, 2017


Download PDF Flyer

http://www.currentdrugdiscoverytechnologies.com/


Current Drug Discovery Technologies

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Vladimir P. Torchilin


Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Scopus CiteScore Metrics: 1.30

Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




New eBook

Frontiers in Clinical Drug Research – Alzheimer Disorders



You can view the contents of this eBook [here] or purchase it [here].

Endorsement(s)

"Modern drug discovery is increasingly driven by scientific integration, the ability to pull together seemingly unrelated branches of basic and applied sciences to produce in a timely fashion innovative and efficacious solutions to multidisciplinary human health problems. The editorial staff is to be congratulated for providing a superb forum for publishing such science and the many and varied new directions that challenge how we think about and address drug discovery."

Paul A. Wender
Stanford University, USA

Forthcoming Special Issue(s)

Thiazole Heterocycle: A Privileged Scaffold for Drug Design and Discovery


Guest Editor(s): Ashok Kumar Datusalia, Gopal L. Khatik
Tentative Publication Date: September, 2017
Submit Abstract via Email Download Description
Authors' Comments
I am very pleased with the quality of service that I received from every part of Bentham Science, including your journal, Current Drug Discovery Technologies. First, let me thank you and the editor for inviting me to submit a review article. The 2nd edition was written as a text for the first semester of the two semester course in medicinal chemistry that is taught in pharmacy schools around the world. Bentham Science is doing a great job of helping my books reach the market.
At the same time, the article I wrote for Current Drug Discovery Technologies gave me an opportunity to reach a broader audience than the one that I reach in my research on food and natural products chemistry at the FDA. It also gave me the opportunity to review the very important subject of allo-network drugs, which has emerged recently and is described in more detail in the 3rd edition. The review process was fast and efficient. It caught the mistakes that I made and recommended several important improvements. The final proofs look excellent.
The other thing that Bentham Science has done for me is to greatly increase my scientific reputation, which has led to several other publishers inviting me to write review articles for them. In conclusion, Bentham Science continues to support my career and I hope that you have found me to be a valuable contributor.

Dr. Robert E. Smith
(U.S. FDA, 11510 W 80th St., Lenexa, KS 66214, USA)

Has contributed: Using NMR to Develop New Allosteric and Allo-Network Drugs

Current Drug Discovery Technologies

,

Volume 14

-

Number 1



Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017Orphan Drugs and Rare Diseases Europe 2017

Related Journals




Related eBooks



Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science